Catalyst Wire Dossier Catalyst Wire Dossier

GAVILYTE-H AND BISACODYL

POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GAVILYTE-H AND BISACODYL, covering 2014-08-20 to 2014-08-20. Get the full timeline:

Most recent: FDA Approved: GAVILYTE-H AND BISACODYL — Original Application (Lupin Pharmaceuticals, Inc.)

See pricing